These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results
Portfolio Pulse from Avi Kapoor
TransMedics Group, Inc. (NASDAQ:TMDX) reported weaker-than-expected quarterly earnings and sales, leading analysts to cut their price targets. Despite the disappointing results, the company remains optimistic about its growth prospects. Analysts from Needham, Baird, and Canaccord Genuity lowered their price targets but maintained positive ratings on the stock.
October 29, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TransMedics Group reported earnings and sales below analyst expectations, leading to a reduction in price targets by several analysts. Despite the miss, the company remains positive about its future growth.
TransMedics' earnings and sales missed expectations, which typically leads to negative short-term stock price movements. Analysts have lowered their price targets, indicating reduced confidence in the stock's near-term performance. However, the company's positive outlook on future growth may mitigate some negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100